Joy Q. Jin

735 total citations
40 papers, 535 citations indexed

About

Joy Q. Jin is a scholar working on Molecular Biology, Immunology and Dermatology. According to data from OpenAlex, Joy Q. Jin has authored 40 papers receiving a total of 535 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 13 papers in Immunology and 10 papers in Dermatology. Recurrent topics in Joy Q. Jin's work include Psoriasis: Treatment and Pathogenesis (11 papers), Dermatology and Skin Diseases (7 papers) and Epigenetics and DNA Methylation (6 papers). Joy Q. Jin is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (11 papers), Dermatology and Skin Diseases (7 papers) and Epigenetics and DNA Methylation (6 papers). Joy Q. Jin collaborates with scholars based in United States, China and Singapore. Joy Q. Jin's co-authors include Biao He, Allison S. Dobry, David M. Jablons, Wilson Liao, Tina Bhutani, Di Zhu, Mei Feng, Etienne Giroux‐Leprieur, Dongsheng Yue and Marwa Hakimi and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Chemical Engineering Journal.

In The Last Decade

Joy Q. Jin

36 papers receiving 532 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joy Q. Jin United States 14 260 153 113 58 55 40 535
Khalifa El Malki Germany 10 138 0.5× 215 1.4× 182 1.6× 43 0.7× 73 1.3× 19 520
Vinodh Kakkassery Germany 13 158 0.6× 108 0.7× 83 0.7× 69 1.2× 82 1.5× 92 754
Weiyan Zheng China 14 240 0.9× 199 1.3× 167 1.5× 36 0.6× 32 0.6× 71 800
Suresh Mohan United States 12 235 0.9× 123 0.8× 70 0.6× 59 1.0× 23 0.4× 39 616
Stéphanie Baillif France 17 172 0.7× 128 0.8× 66 0.6× 17 0.3× 31 0.6× 123 1.1k
Simone Michelini Italy 10 178 0.7× 172 1.1× 71 0.6× 68 1.2× 130 2.4× 41 495
Alessia Bertolotti Italy 14 178 0.7× 150 1.0× 73 0.6× 30 0.5× 23 0.4× 38 517
Pietro Gangemi Italy 9 90 0.3× 91 0.6× 155 1.4× 57 1.0× 24 0.4× 18 454
Melinda Jen United States 10 132 0.5× 96 0.6× 90 0.8× 49 0.8× 74 1.3× 31 441
Jeremy Hurren United Kingdom 13 195 0.8× 198 1.3× 106 0.9× 38 0.7× 29 0.5× 23 635

Countries citing papers authored by Joy Q. Jin

Since Specialization
Citations

This map shows the geographic impact of Joy Q. Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joy Q. Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joy Q. Jin more than expected).

Fields of papers citing papers by Joy Q. Jin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joy Q. Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joy Q. Jin. The network helps show where Joy Q. Jin may publish in the future.

Co-authorship network of co-authors of Joy Q. Jin

This figure shows the co-authorship network connecting the top 25 collaborators of Joy Q. Jin. A scholar is included among the top collaborators of Joy Q. Jin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joy Q. Jin. Joy Q. Jin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gong, Yan, Lili Xia, Joy Q. Jin, et al.. (2025). Broad-spectrum antioxidant and neuroprotective Prussian blue nanocatalyst for therapeutic intervention in autism spectrum disorder. Redox Biology. 84. 103671–103671.
2.
Jin, Joy Q., Cheng Yu, Fan Yuan, et al.. (2025). Biomimetic ferritin nanocages for synergistic co-delivery of metformin and rapamycin restore neurodevelopmental homeostasis in autism spectrum disorders. Journal of Nanobiotechnology. 23(1). 670–670. 1 indexed citations
3.
Xu, Huashan, Fan Yuan, Joy Q. Jin, et al.. (2025). Ferritin nanocages facilitate PROTAC delivery for enhanced targeted therapy in triple-negative breast cancer. Chemical Engineering Journal. 518. 164697–164697. 4 indexed citations
4.
Feng, Shini, Wei Qiao, Lili Xia, et al.. (2025). Nanoengineered, ultrasmall and catalytic potassium calcium hexacyanoferrate for neuroprotection and temporal lobe epilepsy treatment. Science Bulletin. 70(10). 1627–1640. 1 indexed citations
5.
Jin, Joy Q., Marwa Hakimi, Aric A. Prather, et al.. (2024). Psoriasis and Sleep Disturbance: A US Population-Based Study Using the NHANES Database. Dermatology and Therapy. 14(8). 2277–2283. 8 indexed citations
6.
Jin, Joy Q., et al.. (2023). Mendelian Randomization Studies in Atopic Dermatitis: A Systematic Review. Journal of Investigative Dermatology. 144(5). 1022–1037. 15 indexed citations
7.
Siebert, Stefan, Stephen R. Pennington, S. P. Raychaudhuri, et al.. (2023). Novel Insights From Basic Science in Psoriatic Disease at the GRAPPA 2022 Annual Meeting. The Journal of Rheumatology. 50(Suppl 2). 66–70.
8.
Jin, Joy Q., Angel M. Cronin, Carla Roberts‐Toler, et al.. (2023). Sociodemographic and clinical characteristics associated with multiple biologic failure in psoriasis: A 2015-2022 prospective cohort analysis of the CorEvitas psoriasis registry. Journal of the American Academy of Dermatology. 89(5). 974–983. 4 indexed citations
9.
Jin, Joy Q., Julie A. Hong, Edward Hadeler, et al.. (2023). Development of SkinTracker, an integrated dermatology mobile app and web portal enabling remote clinical research studies. Frontiers in Digital Health. 5. 1228503–1228503.
10.
11.
Jin, Joy Q., et al.. (2023). Mendelian Randomization Studies in Psoriasis and Psoriatic Arthritis: A Systematic Review. Journal of Investigative Dermatology. 143(5). 762–776.e3. 17 indexed citations
12.
Jin, Joy Q., et al.. (2023). Risk of Cutaneous T Cell Lymphoma with Psoriasis Biologic Therapies. Dermatology and Therapy. 14(1). 15–30. 7 indexed citations
13.
Jin, Joy Q., et al.. (2023). Apremilast in Palmoplantar Psoriasis and Palmoplantar Pustulosis: A Systematic Review and Meta-analysis. Dermatology and Therapy. 13(2). 437–451. 6 indexed citations
14.
Feng, Mei, Yan Zhou, Shenglin Mei, et al.. (2021). BCL9 regulates CD226 and CD96 checkpoints in CD8+ T cells to improve PD-1 response in cancer. Signal Transduction and Targeted Therapy. 6(1). 313–313. 28 indexed citations
15.
Jin, Joy Q., et al.. (2020). Clinical Characteristics of 18 Patients with Psoriasis and Multiple Myeloma Identified Through Digital Health Crowdsourcing. Dermatology and Therapy. 10(4). 815–827. 8 indexed citations
16.
Zhou, Yang, Joy Q. Jin, Mei Feng, & Di Zhu. (2019). Wnt Signaling in Inflammation in Tissue Repair and Regeneration. Current Protein and Peptide Science. 20(8). 829–843. 18 indexed citations
17.
Mo, Minli, Jie Ma, Chen Zhao, et al.. (2014). Measurement of genome-wide DNA methylation predicts survival benefits from chemotherapy in non-small cell lung cancer. Journal of Cancer Research and Clinical Oncology. 141(5). 901–908. 1 indexed citations
18.
Yue, Dongsheng, Hui Li, Juanjuan Che, et al.. (2014). Hedgehog/Gli promotes epithelial-mesenchymal transition in lung squamous cell carcinomas. Journal of Experimental & Clinical Cancer Research. 33(1). 34–34. 83 indexed citations
19.
Li, Hui, Natalie S. Lui, Tiffany Cheng, et al.. (2013). Gli as a Novel Therapeutic Target in Malignant Pleural Mesothelioma. PLoS ONE. 8(3). e57346–e57346. 28 indexed citations
20.
Jin, Joy Q., et al.. (2012). Hospitalization costs for febrile neutropenia patients in a Singapore university hospital. International Journal of Infectious Diseases. 16. e347–e347. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Khalifa El Malki Breakdown of academic impact, for papers by Vinodh Kakkassery Breakdown of academic impact, for papers by Weiyan Zheng Breakdown of academic impact, for papers by Suresh Mohan Breakdown of academic impact, for papers by Stéphanie Baillif Breakdown of academic impact, for papers by Simone Michelini Breakdown of academic impact, for papers by Alessia Bertolotti Breakdown of academic impact, for papers by Pietro Gangemi Breakdown of academic impact, for papers by Melinda Jen Breakdown of academic impact, for papers by Jeremy Hurren
Rankless by CCL
2026